The landscape of dementia diagnosis has evolved significantly with the advent of sophisticated biomarkers, including amyloid PET scans, tau imaging, and blood-centered assessments which will detect Alzheimer's pathology several years just before signs and symptoms arise. When these technological improvements signify remarkable development in knowing neurodegenerative illnesses, they m... https://michelangelot763tdn3.wikirecognition.com/user